ACHV - Achieve Life Sciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Achieve Life Sciences, Inc.

1040 West Georgia Street
Suite 1030
Vancouver, BC V6E 4H1

Full Time Employees13

Key Executives

NameTitlePayExercisedYear Born
Dr. Richard A. B. StewartChairman & CEO772.64kN/A1959
Dr. Anthony ClarkePres, Chief Scientific Officer & Director603.22kN/A1956
Mr. John A. BencichExec. VP, CFO & COO539.31kN/A1977
Dr. Cindy JacobsExec. VP & Chief Medical Officer593.5kN/A1958
Ms. Jaime XinosExec. VP of CommercialN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes smoking cessation aids in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol; and a strategic collaboration with National Institutes of Health for the development of cytisinicline for smoking cessation. The company is based in Vancouver, Canada.

Corporate Governance

Achieve Life Sciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.